The Office of Rare Diseases Research was established in 1993 within the Office of the Director of the NIH. Its responsibilities were mandated by statute by the Rare Diseases Act of 2002.[2][3] In 2011, the office became part of the newly created NCATS.[4] ORDR is currently headed by Dr. Anne R. Pariser, who took over the position in February 2018.[5]
References
^"Divisions & Offices". National Center for Advancing Translational Sciences. National Institutes of Health. Retrieved 8 July 2018.